West Announces Increase to Fourth-Quarter 2020 Dividend
West Pharmaceutical Services announced a 4Q 2020 dividend increase to $0.17 per share, up from $0.16, marking a 6.25% rise. This dividend is part of the company's commitment to shareholders, representing the 28th consecutive annual increase. The payment will occur on November 18, 2020, for shareholders recorded by November 11, 2020. West's 2019 sales reached $1.84 billion, reflecting ongoing demand for its products in the healthcare sector.
- Dividend increased by 6.25% to $0.17 per share.
- 28th consecutive annual dividend increase.
- Strong sales of $1.84 billion in 2019 demonstrate company stability.
- None.
EXTON, Pa., Oct. 28, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a fourth-quarter 2020 dividend of
About West
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2019 sales of
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:http://www.prnewswire.com/news-releases/west-announces-increase-to-fourth-quarter-2020-dividend-301161236.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
What is the amount of the WST dividend for Q4 2020?
When is the WST dividend payment date?
What is the history of WST's dividend increases?